Monday’s Biggest Analyst Calls: Nvidia, Tesla, Rivian, Best Buy, Taiwan Semiconductor, Coinbase & More

Here are Monday’s biggest calls on Wall Street:

‍

UBS Maintains Bearish View on Tesla

UBS reaffirmed its "sell" rating on Tesla, arguing that the company’s shares remain too expensive. While the firm expects the market's reaction to hinge on Elon Musk’s comments during earnings, they stand by their belief that the stock is fundamentally overvalued.

‍

Bank of America Begins Coverage on Caris Life Sciences

Bank of America initiated coverage of Caris Life Sciences, labeling it a "buy." They described the company as a standout in the biotech sector, praising its unique, data-driven tumor profiling platform and robust financial standing.

‍

Goldman Sachs Backs Nebius Group

Nebius Group, an AI cloud infrastructure provider, earned a "buy" rating from Goldman Sachs. The firm highlighted the company’s role in the fast-growing AI GPU infrastructure rental space and set a 12-month price target of $68, suggesting a 45% upside from current levels.

‍

Citizens Lowers Rating on Goldman Sachs

Citizens downgraded Goldman Sachs to "market perform" from "market outperform," citing that much of their prior bullish thesis has already been realized. At over $700 per share, they believe the stock’s upside is now limited without further catalysts.

‍

Morgan Stanley Starts SPS Commerce Coverage With Overweight Rating

Morgan Stanley gave SPS Commerce an "overweight" rating, noting its strong market presence in Electronic Data Interchange (EDI) services for the retail industry. The firm cited SPS’s vast network of over 500,000 trading partners as a key advantage.

‍

KeyBanc Reaffirms Bullish Outlook on Nvidia

KeyBanc remains bullish on Nvidia, reiterating its "overweight" rating. The firm pointed to growing momentum for Nvidia’s Blackwell and Blackwell Ultra chips, which command higher average selling prices and could lead to further earnings estimate upgrades.

‍

UBS Upgrades American Axle and Visteon

UBS upgraded American Axle from "neutral" to "buy," seeing upside as GM expands U.S. manufacturing and emissions standards ease. The firm also raised Visteon to "buy," citing its durable growth potential from deeper ties with automakers like Toyota.

‍

Piper Sandler Turns Neutral on Best Buy

Piper downgraded Best Buy to "neutral" from "overweight," pointing to a lack of meaningful near-term catalysts. Despite its underperformance year-to-date and modest valuation, the firm doesn’t foresee a reason to be bullish at this time.

‍

Baird Makes Moves on nCino and Henry Schein

nCino received an upgrade from Baird to "outperform," with the firm highlighting renewed momentum in subscription growth. On the other hand, Henry Schein was downgraded to "neutral" over concerns that its largest global client, Heartland Dental, might end its relationship by year’s end.

‍

Citizens Launches Coverage on Hinge Health

Hinge Health was rated "market outperform" by Citizens, following its recent IPO. The firm praised its tech-driven approach to scaling physical therapy services and predicted the company could reshape the healthcare delivery system.

‍

Piper Sandler Pulls Back on Oscar Health and SoundHound

‍Oscar Health was downgraded to "neutral" from "overweight," with Piper expressing concern about its risk/reward profile. SoundHound, an AI-focused company, was similarly downgraded, though Piper retained its $12 price target.

‍

Evercore ISI Adds Guardant Health to Buy List

Guardant Health was initiated as "outperform" by Evercore, which set a $60 price target and sees around 20% upside. The firm views the company as well positioned in the biotech space.

‍

Raymond James and Wells Fargo Upgrade Healthcare Stocks

Paymentus, a digital billing company, was upgraded to "outperform" by Raymond James after a recent pullback. Omega Health Investors (OHI) also received an upgrade from Wells Fargo, which cited an attractive valuation and promising investment opportunities.

‍

Deutsche Bank Upgrades Hyatt Hotels

Deutsche upgraded Hyatt Hotels from "hold" to "buy," forecasting further gains based on what they see as the strongest catalyst pipeline in the lodging sector.

‍

Evercore ISI Downgrades Procter & Gamble

Evercore downgraded Procter & Gamble to "in line" from "outperform," suggesting its expanding portfolio into mid-tier brands may not weather economic pressures as well as in the past.

‍

BTIG Turns Bullish on Synchrony and Bread Financial

Both Synchrony and Bread Financial were upgraded to "buy" by BTIG. The firm cited improving credit performance and better pricing strategies that could help the lenders expand their customer bases.

‍

Needham and William Blair Deliver Positive Initiations and Upgrades

Shopify earned a "buy" rating from Needham with a $135 price target, based on its stable growth trajectory. Stitch Fix was upgraded to "outperform" by William Blair after discussions with company leadership revealed a shift into a growth-focused phase.

‍

Morgan Stanley Highlights Taiwan Semiconductor

Morgan Stanley added Taiwan Semiconductor (TSMC) as a “catalyst-driven idea,” anticipating share gains if the company raises its revenue forecast during upcoming earnings.

‍

Morgan Stanley Downgrades CrowdStrike

Despite its long-term potential, CrowdStrike was downgraded to "equal weight" from "overweight" due to concerns that much of the growth story is already priced in after a 50% rally.

‍

Argus Launches Coverage on Coinbase

Argus began coverage on Coinbase, rating it a "buy" with a $400 price target. The firm described the cryptocurrency exchange as a clear leader in its field.